
Paclitaxel is an anticancer medicine supplied as a concentrate or solution for dilution and intravenous infusion. The product discussed here is Paclitaxel 6 mg/ml 300 mg vial on Vezeeta. It is not an oral tablet and should not be injected at home.
Paclitaxel belongs to the taxane chemotherapy group. It affects microtubules and disrupts cell division. Because it also affects some normal fast-growing cells, side effects can include hair loss, mouth sores, digestive symptoms, and low blood counts.
| FeatureDetails | |
| Brand | Paclitaxel; Taxol is a well-known brand name for paclitaxel |
| Active ingredient | Paclitaxel |
| Strength discussed | 300 mg vial, concentration 6 mg/ml |
| Form | Vial for dilution and intravenous infusion |
| Main use | Chemotherapy for selected cancers |
Paclitaxel may be available in different vial sizes, such as 30 mg, 100 mg, 150 mg, or 300 mg, and in different formulations, including conventional paclitaxel and albumin-bound paclitaxel. These products are not automatically interchangeable. The oncologist selects the formulation, dose, infusion time, and combination medicines according to cancer type, body surface area, liver function, blood tests, previous treatment, and side effects.
Paclitaxel is used in chemotherapy regimens for several cancers, including ovarian cancer, breast cancer, non-small cell lung cancer, and AIDS-related Kaposi sarcoma. It may be used alone or with other anticancer medicines such as carboplatin or cisplatin.
In breast cancer, it may be used after surgery in some higher-risk cases or for metastatic or recurrent disease when the oncology team considers it appropriate.
Cancer treatment should be planned and monitored by a specialist. You can use Vezeeta to book an oncologist for assessment, treatment planning, and follow-up.
Paclitaxel dose is calculated by the oncology team, usually in mg/m² according to body surface area. Common regimens may use 135–175 mg/m² by intravenous infusion at scheduled intervals, but the final dose depends on cancer type, treatment protocol, liver function, blood counts, previous toxicity, and the other drugs used in the same cycle.
Paclitaxel must be diluted before infusion and administered using appropriate equipment by trained healthcare professionals. Patients commonly receive premedication before conventional paclitaxel, such as a corticosteroid, an antihistamine, and an H2 blocker, to reduce the risk of severe allergic reactions. Blood pressure, pulse, breathing symptoms, and the infusion site are monitored during treatment.
Do not try to calculate your own paclitaxel dose. A 300 mg vial does not mean every patient receives exactly 300 mg; the prescribed amount may be less than one vial or more than one vial depending on the protocol.
Paclitaxel is given into a vein, so food does not affect absorption the way it can with tablets. A light meal before chemotherapy may help some patients tolerate treatment, but the chemotherapy unit’s instructions should be followed, especially if blood tests, nausea medicines, or steroids are planned.
If a chemotherapy appointment is missed, contact the oncology unit promptly. Do not make up the dose yourself or change the schedule without medical advice. The team may need to repeat blood tests or check for infection before rescheduling treatment.
Paclitaxel starts acting on dividing cells after infusion, but response is usually assessed after several cycles, not one dose. Doctors may use symptoms, examination, blood tests when appropriate, and scans to judge response. Infusion reactions can happen during treatment, while low blood counts and nerve symptoms may appear later.
Paclitaxel side effects vary according to dose, schedule, combination treatment, and the patient’s general health. Common or important side effects include:
Seek urgent medical help during or after treatment if you develop trouble breathing, swelling of the face or throat, widespread hives, chest pain, fainting, fever, severe diarrhea, severe abdominal pain, unusual bleeding, black stools, confusion, severe weakness, or rapidly worsening numbness or weakness.
Paclitaxel should not be used in patients with a previous severe hypersensitivity reaction to paclitaxel or to medicines formulated with polyoxyl castor oil. It is also generally avoided when baseline neutrophil counts are too low because serious infection risk can increase.
Tell the oncology team before treatment if you have liver disease, heart rhythm or conduction problems, peripheral neuropathy, active infection, unexplained fever, bleeding problems, severe allergies, or recent chemotherapy or radiation. Blood counts and liver tests are usually checked before and during therapy. The infusion site should be watched carefully because leakage outside the vein can irritate tissues.
Paclitaxel is affected by CYP2C8 and CYP3A4 pathways, so interactions may occur with some antifungals, antibiotics, antivirals, seizure medicines, and other cancer medicines. In some platinum-based regimens, sequence matters; paclitaxel is often given before carboplatin or cisplatin when the protocol specifies that order.
Always give the oncology team a complete medication list, including prescription medicines, over-the-counter products, vitamins, herbs, and supplements. Do not start any new medicine during chemotherapy without medical approval.
Paclitaxel can harm an unborn baby and is usually avoided during pregnancy unless the oncology team decides that the potential benefit justifies the risk. Patients who can become pregnant should discuss effective contraception before starting treatment.
Breastfeeding is not recommended during paclitaxel treatment because of potential risk to the infant. If fertility preservation or future pregnancy is important, discuss options before chemotherapy begins.
Paclitaxel is not a daily medicine. It is given in cycles, such as weekly or every few weeks, depending on the regimen. Long-term use depends on response, treatment goal, blood counts, liver function, neuropathy, and overall condition. Toxicity may require dose reduction, delay, or a change in treatment.
Alternatives depend on the cancer type and treatment stage. Options may include docetaxel, albumin-bound paclitaxel, platinum-based regimens, anthracyclines, targeted therapy, immunotherapy, hormone therapy, radiation, surgery, or supportive care. These are not simple substitutes, so paclitaxel should only be replaced by an oncologist’s decision.
The price of paclitaxel in Egypt can change according to availability, vial strength, manufacturer, pharmacy, and pricing updates. For the product discussed here, check the current listing for Paclitaxel 300 mg vial on Vezeeta Pharmacy. Cancer medicines may require a prescription and special handling.
Paclitaxel chemotherapy is an intravenous taxane used for selected cancers. It interferes with cell division and must be given under oncology supervision.
Taxol is a well-known brand name for paclitaxel. A 300 mg vial may be used in treatment plans for breast, ovarian, or lung cancer, or Kaposi sarcoma, when prescribed.
It is diluted and given by intravenous infusion by trained healthcare professionals in a chemotherapy unit or hospital.
Paclitaxel stabilizes microtubules and disrupts normal cell division, which can stop cancer cells from multiplying.
They work in different ways and are commonly combined in some protocols when suitable for the patient.
Many regimens give paclitaxel first because that order is part of established protocol design and may lower some toxicity risks.
The dose is usually based on body surface area in mg/m², then adjusted for cancer type, blood counts, liver function, schedule, and previous side effects.
The cost changes by strength, manufacturer, supply, and pharmacy. In Egypt, check the current Vezeeta product page or a licensed pharmacy.
Most elimination occurs over days, but effects such as low blood counts or neuropathy can last longer depending on dose and schedule.
Yes. Hair loss is common with paclitaxel and often improves after treatment ends, although timing varies.
Yes. Peripheral neuropathy may cause numbness, tingling, burning, or pain in the hands or feet. Report symptoms early.
Taxol is a brand name for paclitaxel. The active ingredient is the same, but formulation, manufacturer, and availability may differ.
The information in this article is provided for general health education and does not replace medical advice from a doctor or pharmacist. Do not start, stop, or change the dose of any medication without consulting a qualified healthcare professional.